Table 1.

Antimycotic sensitivity testing for C. glabrata categorized as susceptible (S) or susceptible at increased exposure (IE) towards the indicated antifungal agents (A) on hospital day 8 and (B) on hospital day 26. Minimum inhibitory concentration (MIC) breakpoints (mg/L) were determined according to the recommendations of the European Committee on Antimicrobial Susceptibility Testing (EUCAST)

Antifungal agent	(A) Sensitivity testing on day 8	(B) Sensitivity testing on day 26
Amphotericin B	S (≤ 0,25 mg/L)	S (1 mg/L)
Voriconazol	IE (0,25 mg/L)	IE (0,25 mg/L)
Caspofungin	S (≤ 0,12 mg/L)	S (0,5 mg/L)
Flucytosin	IE (≤ 1 mg/L)	IE (≤ 1 mg/L)
Micafungin	S (≤ 0,06 mg/L)	S (≤ 0,06 mg/L)